Abstract:The objective of this work was to improve the solubility and discover a stable co-amorphous form of valsartan (VAL), a BCS class-II drug, by utilizing small molecule 2-Aminopyridine (2-AP) in varying molar ratios (2:1, 1:1, and 1:2), employing a solvent evaporation technique. Additionally, by way of a density functional theory (DFT)-based computational method with commercially available software, a new approach for determining the intermolecular connectivity of multi-molecular hydrogen bonding systems was proposed. The binary systems’ features were characterized by PXRD, DSC, FTIR, and Raman spectroscopy, while the equilibrium solubility and dissolution was determined in 0.1 N HCL and water conditions to investigate the dissolution advantage of the prepared co-amorphous systems. The results demonstrated that the co-amorphous system was successfully prepared in VAL/2-AP with a 1:2 molar ratio following solvent evaporation, whereby the hydrogen bonding sites of VAL were fully occupied. Physical stability studies were carried out under dry conditions at room temperature for 6 months. Furthermore, four possible ternary systems were constructed, and their vibrational modes were simulated by DFT calculations. The calculated infrared spectra of the four configurations varied widely, with trimer 1 showing the most resemblance to the experimental spectrum of the co-amorphous 1:2 system. Additionally, co-amorphous VAL/2-AP displayed significant improvement in the solubility and dissolution study. Notably, in the 1:2 ratio, there was almost a 4.5-fold and 15.6-fold increase in VAL’s solubility in 0.1 N HCL and water environments, respectively. In conclusion, our findings highlight the potential of co-amorphous systems as a feasible approach to improving the properties and bioavailabilities of insoluble drugs. The proposed simulation method provides valuable insights into determining the supramolecular structure of multi-molecular hydrogen bonding systems, offering a novel perspective for investigating such systems.

Valsartan/2-Aminopyridine Co-Amorphous System: Preparation, Characterization, and Supramolecular Structure Simulation by Density Functional Theory Calculation

Amino Acids As Co-Amorphous Excipients for Tackling the Poor Aqueous Solubility of Valsartan.

Enhanced dissolution of valsartan-vanillin binary co-amorphous system loaded in mesoporous silica particles

Molecular Insights from Spectral and Computational Studies on Crystalline and Amorphous Telmisartan

Evaluation of Drug Dissolution Rate in Co-amorphous and Co-crystal Binary Drug Delivery Systems by Thermodynamic and Kinetic Methods

In Vitro Dissolution and Physicochemical Characterizations of Novel PVP-based Solid Dispersions Containing Valsartan Prepared by a Freeze-Drying Method.

Combining Co-Amorphous-Based Spray Drying With Inert Carriers To Achieve Improved Bioavailability And Excellent Downstream Manufacturability

The Comparative Study of Cocrystal/salt in Simultaneously Improving Solubility and Permeability of Acetazolamide

Dynamic NMR study and theoretical calculations on the conformational exchange of valsartan and related compounds.

Co-Amorphous Telmisartan-Pimelic Acid with Improved Solubility

Enhanced Dissolution and Oral Bioavailability of Valsartan Solid Dispersions Prepared by a Freeze-Drying Technique Using Hydrophilic Polymers

A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide

Improved in vitro and in vivo properties of telmisartan in the co-amorphous system with hydrochlorothiazide: A potential drug-drug interaction mechanism prediction

Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance

Facile Formation of Co-Amorphous Atenolol and Hydrochlorothiazide Mixtures Via Cryogenic-Milling: Enhanced Physical Stability, Dissolution and Pharmacokinetic Profile.

Preparation and Dissolution of Compound Valsartan and Amlodipine Besylate Tablets

Azilsartan piperazine salt solvate and monohydrate: preparation, crystal structure, enhanced solubility and oral bioavailability

Tranilast-matrine co-amorphous system: Strong intermolecular interactions, improved solubility, and physiochemical stability

An Investigation into Vortioxetine Salts: Crystal Structure, Thermal Stability, and Solubilization.

Design and molecular insights of drug-active metabolite based co-amorphous formulation: A case study of toltrazuril-ponazuril co-amorphous

Salt Hydrates As a Source to Form Co-Amorphous Systems when Prepared in the Absence of Water: Hydrogen Bond Analysis